Vitamin K in cystic fibrosis

Journal of the Royal Society of Medicine, Supplement

Volumn 97, Issue 44, 2004, Pages 48-51

  Conway, S P ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FARNOQUINONE; OSTEOCALCIN; PHYTOMENADIONE; VITAMIN K GROUP;

BLEEDING; BLOOD CLOTTING DISORDER; BONE METABOLISM; CONFERENCE PAPER; CYSTIC FIBROSIS; GENETIC POLYMORPHISM; HUMAN; MEDICAL RESEARCH; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PHENOTYPE; RISK FACTOR; VEGETABLE; VITAMIN K DEFICIENCY;

CYSTIC FIBROSIS; HUMANS; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 2542447553     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Vermeer C, Jie KSG, Knapen MJH. Role of Vitamin K in bone metabolism. Annu Rev Nurt 1995;15:1-22
2. 2 (menanquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994;89:915-23
3. Mayer J. Interaction between vitamin K nutriture and bacterial overgrowth in hypochlorhydria induced by omeprazole. Am J Clin Nutr 1998;68:699-704
4. Ferland G, Sadowski JA, O'Brien ME. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993;91:1761-8
5. Saupe J, Shearer MJ, Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxy glutamate residues of osteocalcin in patients on maintenance haemodialysis. Am J Clin Nutr 1993;58:204-8
6. Shearer MJ. Vitamin K: its physiological role and the assessment of clinical and subclinical deficiency states. JIFCC 1995;7:88-95
7. Weber P. Vitamin K and bone health. Nutrition 2001;17:880-7
8. Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int 1999;65:285
9. Knapen MHJ, Jie KSG, Hamulyak K, Vermeer C. Vitamin K-deficiency redefined. Thromb Haemost 1991;65:671
10. Shearer MJ. Vitamin K. Lancet 1995;345:229-34
11. Vermeer C, Knapen MHJ, Schurgers LJ. Vitamin K and metabolic bone disease. J Clin Pathol 1998;51:424-6
12. Shwachman H. Therapy of cystic fibrosis of the pancreas. Pediatrics 1960;25:155
13. Di Sant'Agnese P, Vidaurreta A. Cystic fibrosis of the pancreas. JAMA 1960;172:2065
14. Torstenson OL, Humphrey GB, Edson JR, Warwick WJ. Cystic fibrosis presenting with severe haemorrhage due to vitamin K malabsorption: a report of 3 cases. Pediatrics 1970;45:857-61
15. Walters TR, Koch HF. Haemorrhagic diathesis and cystic fibrosis in infancy. Am J Dis Child 1972;124:641-2
16. Verghase F, Beverley D. Vitamin K deficient bleeding in cystic fibrosis. Arch Dis Child 2003;88:553
17. Sokol RJ, Reardon MC, Accurso FJ, Stall C, Narkewicz M, Abman SH, et al. Fat soluble vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989;50:1064-71
18. Corrigan JJ, Taussig LM, Beckerman R, Wagener JS. Factor II (prothrombin) coagulant activity and immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. J Pediatr 1981;99:254-7
19. 1 concentrations in cystic fibrosis. Arch Dis Child 1989;64:732-4
20. de Montalembert M, Lenoir G, Saint'Raymond A, Rey J, Lefrere JJ. Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol 1992;45:180-1
21. Cornelissen FAM, van Lieburg AF, Motohara K, van Oostrom CG. Vitamin K status in cystic fibrosis. Acta Pediatr 1992;81:658-61
22. 1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1997;24:512-17
23. Durie PR. Vitamin K and the management of patients with cystic fibrosis Can Med Assoc J 1994;151:933-6
24. Rashid M, Durie P, Andrew M, Kalnins D, Shin J, Corey M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 1999;70:378-82
25. Mosler K, Von Kries R, Vermeer C, Saupe J, Schmitz T, Schuster A. Assessment of vitamin K deficiency in CF: how much sophistication is useful? J Cystic Fibrosis 2003;2:91-6
26. Wilson DC, Rashid M, Durie PR, Tsang A, Kalnins D, Andrew M, et al. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination. Pediatrics 2001;138:851-5
27. Conway SP, Oldroyd B, Wolfe S, Brownlee KG, Truscott JG, Shearer M, et al. Vitamin K status in children with CF and its relationship to bone turnover. J Cystic Fibrosis 2003;2:S88
28. Food and Nutrition Board, Institute of Medicine. Vitamin K. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2001:127
29. Department of Health. Report on health and social subjects no. 41. Dietary reference values for food, energy, and nutrition for the United Kingdom. London: HMSO, 1991
30. National Research Council. Recommended dietary allowances, 10th edn. Washington, DC: National Academy Press, 1989
31. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaloun KL, Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 1997;65:779-84
32. Ramsey BW, Farrell PM, Pencharz P, and the Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16
33. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for paediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-59
34. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HGM, et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cystic Fibrosis 2002;1:51-75
35. Cystic Fibrosis Trust Nutrition Working Group. Nutritional management of cystic fibrosis. London: Cystic Fibrosis Trust, 2002